Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 6
2016 4
2017 4
2018 4
2019 6
2020 9
2021 9
2022 7
2023 2
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Risk for non-sentinel metastases in the contralateral groin in patients with a unilateral positive sentinel lymph node in primary vulvar cancer- a subgroup analysis of the AGO-VOP.2 QS Vulva Study.
Jaeger A, Hampl M, Prieske K, Eulenburg C, Reichenbach J, Klapdor R, Heublein S, Schochter F, Gaß P, Rohner A, Canzler U, Becker S, Bommert M, Bauerschlag D, Denecke A, Hanker L, Runnebaum I, Forner DM, Klar M, Schwab R, Koepke M, Kalder M, Hantschmann P, Ratiu D, Denschlag D, Schroeder W, Tuschy B, Baumann K, Mustea A, Soergel P, Bronger H, Bauerschmitz G, Kosse J, Koch MC, Ignatov A, Sehouli J, Dannecker C, Schmalfeldt B, Mahner S, Woelber L. Jaeger A, et al. Among authors: prieske k. Gynecol Oncol. 2025 Jul 15;200:8-13. doi: 10.1016/j.ygyno.2025.07.003. Online ahead of print. Gynecol Oncol. 2025. PMID: 40669125
Predicting benefit from PARP inhibitors using deep learning on H&E-stained ovarian cancer slides.
Marmé F, Krieghoff-Henning EI, Kiehl L, Wies C, Hauke J, Hahnen E, Harter P, Schouten PC, Brodkorb T, Kayali M, Heitz F, Zamagni C, González-Martin A, Treilleux I, Kommoss S, Prieske K, Gaiser T, Fröhling S, Ray-Coquard I, Pujade-Lauraine E, Brinker TJ. Marmé F, et al. Among authors: prieske k. Eur J Cancer. 2025 Feb 5;216:115199. doi: 10.1016/j.ejca.2024.115199. Epub 2024 Dec 26. Eur J Cancer. 2025. PMID: 39742559 Free article.
Detection of Multiple HPV Types in Liquid Biopsies of Cervical Neoplasia.
Herbst J, Vohl V, Krajina M, Leffers M, Kropidlowski J, Prieske K, Jaeger A, Oliveira Ferrer L, Schmalfeldt B, Goy Y, Burandt E, Pantel K, Vollmert C, Sartori A, Woelber L, Effenberger K, Wikman H. Herbst J, et al. Among authors: prieske k. Clin Chem. 2024 Jan 4;70(1):285-296. doi: 10.1093/clinchem/hvad182. Clin Chem. 2024. PMID: 38175596
The use of colposcopy for triage in HPV-positive women aged 65 years and older.
Kuenkel E, Jaeger A, Bohlmann I, Bergauer F, Kuehler-Obbarius C, Prieske K, Maass-Poppenhusen K, Schmalfeldt B, Woelber L. Kuenkel E, et al. Among authors: prieske k. Arch Gynecol Obstet. 2024 Apr;309(4):1561-1567. doi: 10.1007/s00404-023-07281-5. Epub 2023 Dec 11. Arch Gynecol Obstet. 2024. PMID: 38081959 Free PMC article.
T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell Cancer.
Burandt E, Blessin NC, Rolschewski AC, Lutz F, Mandelkow T, Yang C, Bady E, Reiswich V, Simon R, Sauter G, Mahner S, Gregorio N, Klapdor R, Kalder M, Braicu EI, Fürst S, Klar M, Strauß HG, Prieske K, Wölber L. Burandt E, et al. Among authors: prieske k. Cancers (Basel). 2022 Aug 31;14(17):4246. doi: 10.3390/cancers14174246. Cancers (Basel). 2022. PMID: 36077784 Free PMC article.
Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer Patients.
Leffers M, Herbst J, Kropidlowski J, Prieske K, Bohnen AL, Peine S, Jaeger A, Oliveira-Ferrer L, Goy Y, Schmalfeldt B, Pantel K, Wölber L, Effenberger K, Wikman H. Leffers M, et al. Among authors: prieske k. Cancers (Basel). 2022 Aug 16;14(16):3954. doi: 10.3390/cancers14163954. Cancers (Basel). 2022. PMID: 36010947 Free PMC article.
51 results